BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11694208)

  • 1. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
    Evins AE; Mays VK; Rigotti NA; Tisdale T; Cather C; Goff DC
    Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia.
    Bloch B; Reshef A; Cohen T; Tafla A; Gathas S; Israel S; Gritsenko I; Kremer I; Ebstein RP
    Psychiatry Res; 2010 Jan; 175(1-2):38-42. PubMed ID: 19995670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
    Schmitz JM; Stotts AL; Mooney ME; Delaune KA; Moeller GF
    Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.
    Rovina N; Nikoloutsou I; Katsani G; Dima E; Fransis K; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
    Berrettini WH; Wileyto EP; Epstein L; Restine S; Hawk L; Shields P; Niaura R; Lerman C
    Biol Psychiatry; 2007 Jan; 61(1):111-8. PubMed ID: 16876132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion for smoking cessation: a randomized trial.
    Simon JA; Duncan C; Carmody TP; Hudes ES
    Arch Intern Med; 2004 Sep; 164(16):1797-803. PubMed ID: 15364675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
    Collins BN; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Kaufmann V; Pinto A; Hawk L; Niaura R; Epstein LH; Lerman C
    Nicotine Tob Res; 2004 Feb; 6(1):27-37. PubMed ID: 14982685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
    Dale LC; Ebbert JO; Schroeder DR; Croghan IT; Rasmussen DF; Trautman JA; Cox LS; Hurt RD
    Nicotine Tob Res; 2002 Aug; 4(3):267-74. PubMed ID: 12215235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
    Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC
    Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.
    Evins AE; Cather C; Rigotti NA; Freudenreich O; Henderson DC; Olm-Shipman CM; Goff DC
    J Clin Psychiatry; 2004 Mar; 65(3):307-11; quiz 452-3. PubMed ID: 15096068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
    Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
    J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.